<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Favrille, Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Favrille, Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Favrille_Inc-2523439</link>
<lastBuildDate>Friday, October 10, 2008 11:35:09 PM</lastBuildDate>
<alacra:xlsid>2523439</alacra:xlsid>
<alacra:company>Favrille, Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28240382</link><guid isPermaLink="false">newstex/PRN-0005-28240382</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> SAN DIEGO, Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Favrille, Inc. (Nasdaq: FVRL) today announced that, on September ##, ####, it received a staff determination letter from The Nasdaq Stock Market ("Nasdaq") formally...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016019</newstex:cat><pubDate>9/22/2008 5:21:44 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18013000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Favrille Announces Receipt of Nasdaq Letter</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28240382</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">FAVRILLE INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">FVRL</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1757170</link><guid isPermaLink="false">ccbn/T1757170</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the Q# #### Favrille, Incorporated Earnings Conference Call. My name is Denise, and I'll be your coordinator for today's conference. At this time, all participants are in listen-only mode. We will be conducting a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Mr. Pete De Spain, Director of Investor Relations. Please proceed, sir. ...

</description><pubDate>2/20/2008 12:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">FAVRILLE INC</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 FAVRILLE INC Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">FVRL</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">5:00pm ET</ccbn:time><title>Q4 2007 FAVRILLE INC Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1757170</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1671361</link><guid isPermaLink="false">ccbn/T1671361</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>10/26/2007 2:08:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">FAVRILLE INC</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2007 FAVRILLE INC Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">FVRL</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">5:00pm ET</ccbn:time><title>Q3 2007 FAVRILLE INC Earnings Conference Call Transcript</title><description>...Good day, ladies and gentlemen, and welcome the third quarter #### Favrille, Incorporated Earnings Call. My name is Colby and I will be your operator for today. At this time, all participants are in listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) And as a reminder this conference is being recorded for replay purposes. I would now like to turn the call over to Mr. Pete De Spain, Director of Investor Relations. Please proceed, sir. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1671361</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/1107455880</link><guid isPermaLink="false">srp/1107455880</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:##### Pacific Center Court, Suite ###, San Diego, California ##### Incorporated:DelawareWeb Site: www.favrille.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: Favrille, Inc. is a biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and diseases of the immune system. The company has developed a proprietary technology that enables it to manufacture active immunotherapy product candidates that are designed to stimulate a patient's immune system to mount a specific and sustained response to disease.IPO Date: ##-##-####...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">1107455880</srp:company><title>Favrille, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">312088404</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">FVRL</srp:ticker><pubDate>10/6/2006 12:16:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">1107455880</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>